Bambino Gesù Children's Hospital, 9 Leibniz Institute for Primate Research 10 Polymun Scientific Immunbiologische Forschung GmbH, Nußdorfer Lände, pp.13359-13371 ,
223 62, Sweden. 14 Center for Infectious Medicine, 86, Sweden. 15 Department of Virology. 16 Department of Life and Reproduction Sciences, pp.141-158 ,
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand, New England Journal of Medicine, vol.361, issue.23, pp.2209-2220, 2009. ,
DOI : 10.1056/NEJMoa0908492
Broad Immunogenicity of a Multigene, Multiclade HIV???1 DNA Vaccine Boosted with Heterologous HIV???1 Recombinant Modified Vaccinia Virus Ankara, The Journal of Infectious Diseases, vol.198, issue.10, pp.1482-1490, 2008. ,
DOI : 10.1086/592507
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women, Science, vol.329, issue.5996, pp.1168-1174, 2010. ,
DOI : 10.1126/science.1193748
Microbicides: a new approach to preventing HIV and other sexually transmitted infections, Nature Reviews Drug Discovery, vol.62, issue.12, pp.977-985, 2002. ,
DOI : 10.1038/nrd959
Malaria and HIV/AIDS: Inhibition of Parasitic and Viral Growth by Azurin, Cell Cycle, vol.5, issue.15, pp.1642-1648, 2006. ,
DOI : 10.4161/cc.5.15.2992
Site-specific Discrimination by Cyanovirin-N for ??-Linked Trisaccharides Comprising the Three Arms of Man8 and Man9, Journal of Molecular Biology, vol.322, issue.4, pp.881-889, 2002. ,
DOI : 10.1016/S0022-2836(02)00842-2
Transgenic plant production of Cyanovirin-N, an HIV microbicide, The FASEB Journal, vol.20, pp.356-358, 2006. ,
DOI : 10.1096/fj.05-4742fje
Innate immunity against HIV: a priority target for HIV prevention research, Retrovirology, vol.7, issue.1, p.84, 2010. ,
DOI : 10.1186/1742-4690-7-84
Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses, Vaccine, vol.27, issue.2, pp.184-186, 2009. ,
DOI : 10.1016/j.vaccine.2008.10.041
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children, Vaccine, vol.29, issue.39, 2011. ,
DOI : 10.1016/j.vaccine.2010.12.058
Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials, Nature Reviews Immunology, vol.12, issue.10, pp.717-728, 2009. ,
DOI : 10.1038/nri2636
Assessment of mucosal immunity to HIV-1, Expert Review of Vaccines, vol.9, issue.4, pp.381-394, 2010. ,
DOI : 10.1586/erv.10.21
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene, Science, vol.258, issue.5090, pp.1938-1941, 1992. ,
DOI : 10.1126/science.1470917
HIV vaccine design: insights from live attenuated SIV vaccines, Nature Immunology, vol.83, issue.1, pp.19-23, 2006. ,
DOI : 10.1038/ni1296
Macaques Infected with Live Attenuated SIVmac Are Protected against Superinfection via the Rectal Mucosa, Virology, vol.229, issue.1, pp.143-154, 1997. ,
DOI : 10.1006/viro.1996.8419
T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6, Journal of Internal Medicine, vol.320, issue.1, pp.67-77, 2009. ,
DOI : 10.1111/j.1365-2796.2008.02051.x
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus, Proceedings of the National Academy of Sciences, vol.101, issue.9, pp.3017-3022, 2004. ,
DOI : 10.1073/pnas.0308677101
Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus., Journal of General Virology, vol.78, issue.8, pp.781923-1927, 1997. ,
DOI : 10.1099/0022-1317-78-8-1923
Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution, Retrovirology, vol.5, issue.1, p.44, 2008. ,
DOI : 10.1186/1742-4690-3-2
Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Nontranscriptional Function of Tat in Viral Replication, Journal of Virology, vol.81, issue.20, pp.11159-11169, 2007. ,
DOI : 10.1128/JVI.01354-07
Flow cytometric characterization of the lymphocyte composition in a variety of mucosal tissues in healthy rhesus macaques, Journal of Medical Primatology, vol.859, issue.Suppl A, pp.41-51, 2010. ,
DOI : 10.1111/j.1600-0684.2010.00446.x
Strong virus-specific mucosal immune responses in SIVinfected rhesus monkeys significantly contribute to viral containment and long-term survival, 2010. ,
How to break oral tolerance to make an efficient HIV vaccine: lessons from animal model?, 2010. ,
Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8), Journal of General Virology, vol.89, issue.9, pp.2240-2251, 2008. ,
DOI : 10.1099/vir.0.2008/001693-0
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines, Science, vol.258, issue.5090, pp.1935-1938, 1992. ,
DOI : 10.1126/science.1470916
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus, J Virol, vol.69, pp.3117-3124, 1995. ,
Complement-Mediated Enhancement of HIV-1 Neutralisation by Anti-HLA Antibodies Derived from Polytransfused Patients, International Archives of Allergy and Immunology, vol.131, issue.1, pp.62-72, 2003. ,
DOI : 10.1159/000070437
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report, PLoS ONE, vol.71, issue.2, p.4505, 2009. ,
DOI : 10.1371/journal.pone.0004505.s002
Plaque-Reduction Assays for Human and Simian Immunodeficiency Virus Neutralization, Methods Mol Biol, vol.304, pp.273-285, 2005. ,
DOI : 10.1385/1-59259-907-9:273
Viral characterization and humoral immune response to HIV in the setting of acute HIV infection, Aids Research and Human Retroviruses, vol.26, 2010. ,
http://www.translational-medicine.com/content, Journal of Translational Medicine, vol.91, issue.9, p.4040, 2011. ,
Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children, AIDS, vol.24, issue.16, pp.2527-2533, 2010. ,
DOI : 10.1097/QAD.0b013e32833d7d8c
Cross???Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression, The Journal of Infectious Diseases, vol.201, issue.7, pp.1045-1053, 2010. ,
DOI : 10.1086/651144
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm, Journal of Virology, vol.83, issue.14, pp.7337-7348, 2009. ,
DOI : 10.1128/JVI.00110-09
Rapid Escape from Preserved Cross-Reactive Neutralizing Humoral Immunity without Loss of Viral Fitness in HIV-1-Infected Progressors and Long-Term Nonprogressors, Journal of Virology, vol.84, issue.7, pp.3576-3585, 2010. ,
DOI : 10.1128/JVI.02622-09
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level, Nature Medicine, vol.81, issue.9, pp.995-997, 2010. ,
DOI : 10.1038/nm.2203
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1, Science, vol.329, issue.5993, pp.856-861, 2010. ,
DOI : 10.1126/science.1187659
Antibodies Mediating Cellular Cytotoxicity and Neutralization Correlate with a Better Clinical Stage in Children Born to Human Immunodeficiency Virus-Infected Mothers, Journal of Infectious Diseases, vol.161, issue.2, pp.198-202, 1990. ,
DOI : 10.1093/infdis/161.2.198
Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection, AIDS Research and Human Retroviruses, vol.6, issue.3, pp.341-356, 1990. ,
DOI : 10.1089/aid.1990.6.341
Fc receptor-mediated antiviral antibodies, Current Opinion in HIV and AIDS, vol.4, issue.5, pp.388-393, 2009. ,
DOI : 10.1097/COH.0b013e32832f0a89
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882066
Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children, Proceedings of the National Academy of Sciences, vol.106, issue.19, pp.7939-7944, 2009. ,
DOI : 10.1073/pnas.0901702106
HLA-C increases HIV-1 infectivity and is associated with gp120, Retrovirology, vol.5, issue.1, p.68, 2008. ,
DOI : 10.1186/1742-4690-5-68
Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation, J Virol, vol.73, pp.7515-7523, 1999. ,
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients, Blood, vol.111, issue.8, pp.4209-4219, 2008. ,
DOI : 10.1182/blood-2007-05-092429
Dendritic cells sample HIV-1 through an intestinal epithelial cell monolayer, Retrovirology, vol.6, issue.Suppl 1, 2009. ,
DOI : 10.1186/1742-4690-6-S1-O4
URL : http://doi.org/10.1186/1742-4690-6-s1-o4
Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+ T lymphocytes, a transciptome analysis, 2010. ,
HIV Vaccine Research: The Way Forward, Science, vol.321, issue.5888, pp.530-532, 2008. ,
DOI : 10.1126/science.1161000
Predictive value of primate models for AIDS, AIDS Rev, vol.6, pp.187-198, 2004. ,